Stay updated on Flutiform K-haler Clinical Trial

Sign up to get notified when there's something new on the Flutiform K-haler Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Flutiform K-haler Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    Change Detected
    Summary
    The study has been updated to version v2.10.0, replacing the previous version v2.9.7.
    Difference
    0.5%
    Check dated 2024-07-23T14:56:39.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T08:12:05.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-07-02T13:30:07.000Z thumbnail image
  8. Check
    30 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-27T09:26:34.000Z thumbnail image
  9. Check
    31 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-26T08:30:12.000Z thumbnail image
  10. Check
    32 days ago
    Change Detected
    Summary
    The value 'Show more Show more Revision: v2.9.0' has recently changed to 'Show less MedlinePlus related topics: Asthma FDA Drug and Device Resources Show less Design Details Primary Purpose : Treatment Allocation : N/A Interventional Model : Single Group Assignment Masking : None (Open Label) Arms and Interventions Participant Group/Arm Intervention/Treatment Experimental : Brand Name: Flutiform K-haler Brand Name: Flutiform K-haler Generic name: Fluticasone/formoterol dosage form: oral inhalation Drug : Brand Name: Flutiform K-haler Brand Name: Flutiform K-haler Generic name: Fluticasone/formoterol dosage form: oral inhalation Other Names: Flutiform K-haler Primary Outcome Measures Outcome Measure Measure Description Time Frame The primary endpoint of the study is the change in Asthma control test from baseline to Week 12 on treatment change in Asthma control test from baseline to Week 12 on treatment Week 0, Week 12 Additional Relevant MeSH Terms Bronchial Diseases Respiratory Tract Diseases Lung Diseases, Obstructive Lung Diseases Respiratory Hypersensitivity Hypersensitivity, Immediate Hypersensitivity Immune System Diseases Asthma Studies a U.S. FDA-Regulated Drug Product No Studies a U.S. FDA-Regulated Device Product No Revision: v2.9.1.' This change represents an update in the study details and primary outcome measures of the clinical trial related to Flutiform K-haler in asthma patients.
    Difference
    10%
    Check dated 2024-06-25T08:05:01.000Z thumbnail image

Stay in the know with updates to Flutiform K-haler Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Flutiform K-haler Clinical Trial page.